Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

GW PHARMACEUTICALS PLC (GWPH)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Sep-30-18Sep-30-16
   10-K10-K8-K10-KSource
Revenues:  
    United States  467.6288.2 1.6 
    United Kingdom  10.82.6 1.8 
    Other  48.820.6 9.4 
Total revenues   [+]527.2311.315.412.712.7
            Revenue growth   [+]69.3%1921.8%   
Cost of goods sold  37.527.26.66.03.8
Gross profit  489.7284.18.86.88.9
            Gross margin  92.9%91.3%56.9%53.0%70.0%
Selling, general and administrative  336.0259.9165.7141.833.2
Research and development  205.4142.7 153.7104.4
Other operating expenses    146.6  
EBITDA   [+]-39.0-109.2-293.9-279.5-123.5
            EBITDA margin  -7.4%-35.1%-1908.8%-2194.5%-970.2%
Depreciation and amortization  12.89.29.79.35.2
EBIT   [+]-51.8-118.4-303.6-288.8-128.7
            EBIT margin  -9.8%-38.0%-1971.6%-2267.4%-1010.6%
Interest income, net   [+]0.77.44.32.40.4
Other income (expense), net   [+]-4.0101.8-6.1-5.035.9
Pre-tax income  -55.0-9.2-305.4-291.4-92.4
Income taxes  3.1-0.2-0.23.8-0.7
            Tax rate   2.0%0.1% 0.8%
Net income  -58.1-9.0-305.3-295.2-91.7
            Net margin  -11.0%-2.9%-1982.3%-2317.4%-720.3%
   
Basic EPS   [+]($0.15)($0.02)($0.88)($0.88)($0.34)
Diluted EPS   [+]($0.15)($0.02)($0.88)($0.88)($0.34)
   
Shares outstanding (basic)   [+]375.6371.6347.1333.9272.2
Shares outstanding (diluted)   [+]375.6371.6347.1333.9272.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy